The following is a summary of “Efficacy of acetylcholinesterase inhibitors on reducing hippocampal atrophy rate: a systematic review and meta-analysis,” published in the February 2025 issue of BMC ...

Secondly, it turns out that “at least” one in 10 cases of dementia are “mixed”, according to the Alzheimer’s Society, meaning ...

Donepezil treatment was started 12 weeks before the second PET scan at a dose of 5 mg/day for four weeks, then increased to 10 mg/day. Three visits were conducted during the study: at baseline and ...

Each participant received four 5-week blocks of treatment: drug only (5 mg daily dose of donepezil) drug and Earobics (10 mg daily dose of donepezil, plus two 40 min daily sessions of Earobics) ...

The approvals provide therapies for dementia, oncology and gastrointestinal disease. Ozempic has been approved to reduce the risk of worsening kidney disease and cardiovascular death in adults ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. We’ve spent hours evaluating each of the programs below based around the extra features ...

The company announced today that it has launched memantine/donepezil extended-release capsules for Alzheimer's-related dementia, with an exclusive 180-day marketing period. Additionally ...

has approved memantine/donepezil 14-10 mg and 28-10 mg extended-release capsules, which references Abbvie’s NAMZARIC ®, and Everolimus 2 mg, 3 mg and 5 mg extended-release capsules, which ...

and donepezil as Aricept, are also available as single ingredient products. Currently, the treatment is available in 28 mg/10 mg (memantine extended release/donepezil), and 14 mg/10mg for patients ...

has approved memantine/donepezil 14-10 mg and 28-10 mg extended-release capsules, which references Abbvie’s NAMZARIC®, and Everolimus 2 mg, 3 mg and 5 mg extended-release capsules, which ...

0.57 ± 0.21, p > 0.05). Donepezil (1 μM) potently increased by 2.6-fold the spontaneous firing frequency, which was prevented by the muscarinic receptor antagonist atropine (10 μM). (2) The CARS-2 ...